Antibodies Inc. Unveils a Revolutionary Antibody for Retinal Research
Antibodies Inc., a pioneer in providing validated life science research reagents, is thrilled to announce the launch of its new Recombinant Guinea Pig RBPMS Antibody (Clone OTI3B7-GP, Cat. No. 1834-RBPMS). This state-of-the-art antibody is designed specifically for retinal ganglion cell (RGC) research, offering unparalleled performance, specificity, and reproducibility.
The Recombinant Guinea Pig RBPMS Antibody is a proud addition to the PhosphoSolutions brand, which is known for its high-quality neuroscience reagents. This innovation builds upon Antibodies Inc.'s commitment to thorough validation, advanced manufacturing techniques, and an effective global distribution network. The new mAb replaces the previous guinea pig polyclonal RBPMS Antibody (Cat. No. 1832-RBPMS), ensuring researchers benefit from the latest advancements in antibody technology.
Importance of RBPMS in Research
RBPMS, which stands for RNA Binding Protein with Multiple Splicing, has become a gold standard for identifying retinal ganglion cells. By providing accurate cell identification and helping with quantification in studies focused on vision and neurodegeneration, this antibody plays a crucial role in advancing research in these fields. Traditional polyclonal antibodies, while useful, often present challenges such as variability between lots and limited availability.
Advancements with Recombinant Antibody Technology
The Recombinant Guinea Pig RBPMS Antibody (OTI3B7-GP) effectively overcomes these limitations through sophisticated recombinant engineering. This approach removes issues related to lot variability and stock constraints. By integrating a tried and tested antigen-binding region from the OTI3B7 clone with a guinea pig IgG constant region, this antibody promotes efficient multiplexing alongside other antibody types, such as mouse and rabbit antibodies, while maintaining consistent performance over time.
Key advantages of the Recombinant Guinea Pig RBPMS Antibody include:
- A dedicated antibody for the identification of retinal ganglion cells.
- A guinea pig format optimized for advanced multiplex immunolabeling techniques.
- The inclusion of the well-defined OTI3B7-GP clone, featuring a specific amino acid sequence.
- Production that is animal-free and serum-free, enhancing its ethical profile.
- High reproducibility between lots, making it ideal for longitudinal studies and multi-site research initiatives.
Validated Applications
This new antibody has undergone rigorous validation for various applications, including immunohistochemistry (IHC) and Western blotting. Researchers can expect clear and specific labeling of retinal ganglion cells in samples from mammals, ensuring their experiments provide reliable and reproducible results, which is vital in high-stakes research.
The introduction of the Recombinant Guinea Pig RBPMS Antibody is a testament to Antibodies Inc.’s ongoing dedication to fostering scientific innovation and exploration through a robust and expanding portfolio of specialized research brands.
Explore More from Antibodies Inc.
For researchers looking into alternative RBPMS antibodies, Antibodies Inc. also offers a Rabbit Polyclonal RBPMS Antibody. For a comprehensive view of their entire offering, researchers are encouraged to delve into the PhosphoSolutions product line provided by Antibodies Inc., which caters to various research needs in neuroscience and related disciplines.
Researchers can now take advantage of the Recombinant Guinea Pig RBPMS Antibody (OTI3B7-GP, 1834-RBPMS), which is readily available through Antibodies Inc. and its authorized distributors across the globe.
About Antibodies Inc.
Antibodies Inc. is dedicated to equipping researchers worldwide with rigorously tested antibodies, recombinant proteins, ELISA kits, and custom services. Through an expanding collection of specialized brands such as PhosphoSolutions, Antibodies Inc. aims to accelerate scientific discovery across fields like neuroscience, cell biology, and translational research.
Frequently Asked Questions
What is the Recombinant Guinea Pig RBPMS Antibody used for?
This antibody is primarily used for identifying retinal ganglion cells in research related to vision and neurodegeneration.
What advantages does the recombinant version have over polyclonal antibodies?
The recombinant version eliminates lot-to-lot variability, ensuring consistency and reliability in experiments.
What applications has the antibody been validated for?
It has been validated for immunohistochemistry (IHC) and Western blotting in mammalian tissue samples.
Is the antibody produced ethically?
Yes, it is produced in an animal-free, serum-free format, adhering to ethical research standards.
Where can I purchase the Recombinant Guinea Pig RBPMS Antibody?
It is available through Antibodies Inc. and their authorized global distributors.
